ReVision Optics Sees $35M

Lake Forest-based ReVision Optics, a developer of implantable lenses for treating presbyopia, has received $35.0M in a new round of venture funding, according to a regulatory filing by the firm Tuesday. Details on the funding have not yet been announced by the company. According to the filing, the round included 11 investors. ReVision Optics has previously raised funding from Domain Associates, Canaan Partners, and InterWest Partners. ReVision's PresbyLens is targeted at near and intermediate vision enhancement, and is currently approved in Europe; the firm said it is planning U.S. clinical trials soon. More information »